JANSSEN ALZHEIMER IMMUNOTHERAPY;NEURALAB LIMITED;CRIMAGUA LIMITED;ELAN PHARMA INTERNATIONAL LTD.
发明人:
申请号：
IL18752607
公开号：
IL187526A
申请日:
2007.11.20
申请国别(地区):
IL
年份:
2013
代理人:
摘要：
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A² in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A² and antibodies binding to the same.
